LobbyingThe Biosimilars Forum lobbying by quarter
The Biosimilars Forum's latest lobbying report covers Q2 2026, at $100K. The four quarters Q4 2025–Q3 2026 total $300K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
The Biosimilars Forum
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $300K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $90K | 1 |
| Q1 2023 | $90K | 1 |
| Q2 2023 | $90K | 1 |
| Q3 2023 | $110K | 1 |
| Q4 2023 | $110K | 1 |
| Q1 2024 | $100K | 1 |
| Q2 2024 | $100K | 1 |
| Q3 2024 | $100K | 1 |
| Q4 2024 | $100K | 1 |
| Q1 2025 | $100K | 1 |
| Q2 2025 | $100K | 1 |
| Q3 2025 | $100K | 1 |
| Q4 2025 | $100K | 1 |
| Q1 2026 | $100K | 1 |
| Q2 2026 | $100K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$745K · 15 reports
- Medicare and Medicaid$745K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)15 reports
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Health & Human Services, Dept of (HHS)9 reports
Firms it paid
| Firm | ||
|---|---|---|
| Thorn Run Partners | $1.5M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ALEX DELPIZZO | Legislative Director/Legislative Asst, Rep. Ferguson; Staff Asst, House Transportation and Infrastructure Committee | Q2 2026 |
| STUART CHAPMAN | Chief of Staff, Representative Carolyn McCarthy; Chief of Staff, Representative Zack Space; Press Secretary, Senator Jay Rockefeller; Press Secretary, Representative Barbara Lee | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | Thorn Run Partners | $100K |
| 04/18for Q1 | Thorn Run Partners | $100K |
| 01/20for Q4 2025 | Thorn Run Partners | $100K |
| 25/10/20for Q3 2025 | Thorn Run Partners | $100K |
| 25/07/16for Q2 2025 | Thorn Run Partners | $100K |
| 25/04/17for Q1 2025 | Thorn Run Partners | $100K |
| 25/01/19for Q4 2024 | Thorn Run Partners | $100K |
| 24/10/17for Q3 2024 | Thorn Run Partners | $100K |
| 24/07/20for Q2 2024 | Thorn Run Partners | $100K |
| 24/04/22for Q1 2024 | Thorn Run Partners | $100K |
| 24/01/22for Q4 2023 | Thorn Run Partners | $110K |
| 23/10/20for Q3 2023 | Thorn Run Partners | $110K |
| 23/07/20for Q2 2023 | Thorn Run Partners | $90K |
| 23/04/20for Q1 2023 | Thorn Run Partners | $90K |
| 23/01/20for Q4 2022 | Thorn Run Partners | $90K |